Product Introduction:
Liftaz Injection contains a combination of Ceftriaxone (1000 mg) and Tazobactam (125 mg). Ceftriaxone is a third-generation cephalosporin antibiotic effective against a wide range of bacteria, while Tazobactam is a beta-lactamase inhibitor that protects ceftriaxone from enzymatic degradation, making the combination more effective against resistant strains.
Uses:
-
Lower and upper respiratory tract infections
-
Intra-abdominal infections
-
Urinary tract infections
-
Skin and soft tissue infections
-
Bone and joint infections
-
Sepsis and septicemia
-
Postoperative infections
Benefits:
-
Enhanced action against beta-lactamase producing bacteria
-
Effective in treating serious, complicated infections
-
Broad-spectrum antibacterial coverage
-
Used in both hospital and critical care settings
Composition (per 10 ml vial):
-
Ceftriaxone 1000 mg
-
Tazobactam 125 mg
Side Effects:
-
Pain, swelling or redness at injection site
-
Diarrhea or loose stools
-
Rash or allergic reactions
-
Headache or dizziness
-
Rarely, liver enzyme elevation or blood disorders
Safety Advice:
-
Should be administered only by a healthcare professional
-
Dosage and duration to be determined by the physician based on infection severity
-
Use with caution in patients with kidney or liver disease
-
Not to be mixed with calcium-containing IV fluids
-
Complete the prescribed course even if symptoms improve early
